SynthesisDiabetic medicine : a journal of the British Diabetic Association2026

A systematic review and meta-analysis of the relative benefit of dual versus single oral hypoglycaemic therapy following diagnosis with type 2 diabetes (T2D).

What the trial testedas reported · 2026

No range given

+55%

Bigger than 3 in 10 for glycemic control

As reported

OR 1.55, no interval

the abstract, start to end

… compared to 81% with metformin alone (OR 1.55, p ≤ 0.001), a difference …

← favours treatmentfavours comparator →

could be chance

No interval given · direction only, strength unknown

Glycemic control

OR 1.55

MetforminGlycemic control

1 / 3